UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Scale-up for bulk production of vaccine against meningococcal disease

Vaccine, 2007-08, Vol.25 (34), p.6399-6408

2007

Volltextzugriff (PDF)

Evaluation of a critical process parameter: Oxygen limitation during cultivation has a fully reversible effect on gene expression of Bordetella pertussis

Biotechnology and bioengineering, 2009, Vol.102 (1), p.161-167

2009

Volltextzugriff (PDF)

Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes

Genome Biology, 2007-07, Vol.8 (7), p.R136-R136

2007

Volltextzugriff (PDF)

Modeling Neisseria meningitidis B metabolism at different specific growth rates

Biotechnology and bioengineering, 2008-12, Vol.101 (5), p.1022-1035

2008

Volltextzugriff (PDF)

PAT for vaccines: The first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease

Vaccine, 2007-04, Vol.25 (16), p.2994-3000

2007

Volltextzugriff (PDF)

Process analytical technology (PAT) tools for the cultivation step in biopharmaceutical production

Engineering in life sciences, 2013-05, Vol.13 (3), p.212-223

2013

Volltextzugriff (PDF)

Manufacturing Vaccines: An Illustration of Using PAT Tools for Controlling the Cultivation of Bordetella pertussis

Quality engineering, 2007-10, Vol.19 (4), p.373-384

2007

Volltextzugriff (PDF)

Preparation and application of a fluorescein-labeled peptide for determining the affinity constant of a monoclonal antibody-hapten complex by fluorescence polarization

Analytical biochemistry, 1991-08, Vol.196 (2), p.421-426

1991

Volltextzugriff (PDF)

Preparation of clinical grade monoclonal antibodies from serum-containing cell culture supernatants

Journal of immunological methods, 1991-04, Vol.138 (2), p.273-283

1991

Volltextzugriff (PDF)

Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease

The Journal of infectious diseases, 1992-06, Vol.165 Suppl 1, p.S152

1992

Volltextzugriff (PDF)

Analysis of glycoforms present in two mouse IgG2a monoclonal antibody preparations

Journal of immunological methods, 1992-11, Vol.155 (2), p.241-248

1992

Volltextzugriff (PDF)

Two-step purification of a murine monoclonal antibody intended for therapeutic application in man: Optimisation of purification conditions and scaling up

Journal of immunological methods, 1989-11, Vol.124 (1), p.143-156

1989

Volltextzugriff (PDF)

Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen

Vaccine, 1996-12, Vol.14 (17), p.1627-1632

1996

Volltextzugriff (PDF)

Purification and stabilization of a poorly soluble mouse IgG3 monoclonal antibody

Journal of immunological methods, 1991-04, Vol.138 (2), p.181-189

1991

Volltextzugriff (PDF)

Viability measurements of hybridoma cells in suspension cultures

Cytotechnology (Dordrecht), 1992-01, Vol.8 (1), p.57-64

1992

Volltextzugriff (PDF)

The potential of flow cytometric analysis for the characterization of hybridoma cells in suspension cultures

Cytotechnology (Dordrecht), 1992-01, Vol.8 (1), p.65-74

1992

Volltextzugriff (PDF)

Randomised, controlled trial with the trypsin-modified inactivated poliovirus vaccine: assessment of intestinal immunity with live challenge virus

Vaccine, 1999-03, Vol.17 (9), p.1084-1090

1999

Volltextzugriff (PDF)

Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice

Infection and Immunity, 1983-08, Vol.41 (2), p.609-617

1983

Volltextzugriff (PDF)

On the structure of immune-stimulating saponin-lipid complexes (iscoms)

Biochimica et biophysica acta, 1991-02, Vol.1062 (2), p.165-171

1991

Volltextzugriff (PDF)

Analytical approaches to the study of monoclonal antibody stability

Pharmaceutical research, 1990-12, Vol.7 (12), p.1234-1241

1990

Volltextzugriff (PDF)

Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine

Infection and Immunity, 1982-08, Vol.37 (2), p.579-585

1982

Volltextzugriff (PDF)

Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants

Vaccine, 1995, Vol.13 (2), p.168-174

1995

Volltextzugriff (PDF)

The influence of sucrose, dextran, and hydroxypropyl-β-cyclodextrin as lyoprotectants for a freeze dried mouse IgG2a monoclonal antibody (MN12)

Pharmaceutical research, 1992-02, Vol.9 (2), p.266-270

1992

Volltextzugriff (PDF)

Immunogenicity of a pilot inactivated poliovirus vaccine with trypsin-treated type 3-component

Vaccine, 1997-02, Vol.15 (2), p.237-243

1997

Volltextzugriff (PDF)

Inactivated Poliovirus Vaccine Protects Transgenic Poliovirus Receptor Mice against Type 3 Poliovirus Challenge

The Journal of infectious diseases, 1997-02, Vol.175 (2), p.441-444

1997

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Scale-up for bulk production of vaccine against meningococcal disease

Evaluation of a critical process parameter: Oxygen limitation during cultivation has a fully reversible effect on gene expression of Bordetella pertussis

Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes

Modeling Neisseria meningitidis B metabolism at different specific growth rates

PAT for vaccines: The first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease

Process analytical technology (PAT) tools for the cultivation step in biopharmaceutical production

Manufacturing Vaccines: An Illustration of Using PAT Tools for Controlling the Cultivation of Bordetella pertussis

Preparation and application of a fluorescein-labeled peptide for determining the affinity constant of a monoclonal antibody-hapten complex by fluorescence polarization

Preparation of clinical grade monoclonal antibodies from serum-containing cell culture supernatants

Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease

Analysis of glycoforms present in two mouse IgG2a monoclonal antibody preparations

Two-step purification of a murine monoclonal antibody intended for therapeutic application in man: Optimisation of purification conditions and scaling up

Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen

Purification and stabilization of a poorly soluble mouse IgG3 monoclonal antibody

Viability measurements of hybridoma cells in suspension cultures

The potential of flow cytometric analysis for the characterization of hybridoma cells in suspension cultures

Randomised, controlled trial with the trypsin-modified inactivated poliovirus vaccine: assessment of intestinal immunity with live challenge virus

Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice

On the structure of immune-stimulating saponin-lipid complexes (iscoms)

Analytical approaches to the study of monoclonal antibody stability

Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine

Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants

The influence of sucrose, dextran, and hydroxypropyl-β-cyclodextrin as lyoprotectants for a freeze dried mouse IgG2a monoclonal antibody (MN12)

Immunogenicity of a pilot inactivated poliovirus vaccine with trypsin-treated type 3-component

Inactivated Poliovirus Vaccine Protects Transgenic Poliovirus Receptor Mice against Type 3 Poliovirus Challenge

Suchergebnisse filtern